Science Advance: Quality of Life is Improved & Kidney Function Preserved in Patients with Nephropathic Cystinosis Treated for 2 Years with Delayed-Release Cysteamine Bitartrate

By ACTSI investigator Larry Greenbaum, MD, PhD et al. in The Journal of Pediatrics.  

Upcoming Events

    View All Events

    Latest News


    ACTSI-supported OculoStaple Wins Again

    Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...


    Infographic: What are the Phases of Clinical Trials?